Honored to present results of ongoing phase I/II study of INT230-6 at #SITC2019 and excited for the future of this drug that is helping our patients!

Finally got my business card! Accepting all melanoma, sarcoma, and phase I clinical trial patients in sunny OC 😎 @ Newport Beach, California instagram.com/p/BnKOhSPgIFEA…